How to evaluate microvascular organ damage in hypertension: Assessment of endothelial function

High Blood Pressure and Cardiovascular Prevention

Volumn 18, Issue 4, 2011, Pages 163-167

  Virdis, Agostino ^a   Taddei, Stefano ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

endothelium; hypertension; microcirculation; nitric oxide

Indexed keywords

ASCORBIC ACID; CALCIUM ANTAGONIST; CYTOCHROME P450; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; INDOMETACIN; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OUABAIN; SALBUTAMOL; SULFAPHENAZOLE;

ANGIOGRAPHY; ARTERIOLE; AUTOCRINE EFFECT; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; CARDIAC PATIENT; CELL ACTIVATION; CELL FUNCTION; CLINICAL ASSESSMENT; CLINICAL RESEARCH; CORONARY ARTERY BLOOD FLOW; CORONARY BLOOD VESSEL; DOPPLER FLOWMETER; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME ACTIVITY; ESSENTIAL HYPERTENSION; EX VIVO STUDY; FOREARM; HUMAN; IN VITRO STUDY; INTRACORONARY INFUSION; LASER DOPPLER FLOWMETRY; MICROCIRCULATION; MICROVASCULARIZATION; MUSCLE; MYOGRAPHY; OXIDATIVE STRESS; PARACRINE SIGNALING; PERIPHERAL VASCULAR DISEASE; PLETHYSMOGRAPHY; PRIORITY JOURNAL; RESISTANCE BLOOD VESSEL; REVIEW; SHEAR STRESS; SUBCUTANEOUS TISSUE; TONOMETRY;

CORONARY ANGIOGRAPHY; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; FOREARM; HUMANS; HYPERTENSION; LASER-DOPPLER FLOWMETRY; MICROCIRCULATION; MYOGRAPHY; PLETHYSMOGRAPHY; SKIN;

EID: 84856390933     PISSN: 11209879     EISSN: 11791985     Source Type: Journal    
DOI: 10.2165/11593630-000000000-00000     Document Type: Review

References (21)

1. Virdis A, Ghiadoni L, Versari D, et al. Endothelial function assessment in complicated hypertension. Curr Pharm Des 2008; 14 (18): 1761-70 (Pubitemid 351998580)
2. Touyz RM. Oxidative stress and vascular damage in hypertension. Curr Hypertens Rep 2000; 2 (1): 98-105
3. Lerman A, Zeiher AM. Endothelial function: cardiac events. Circulation 2005; 111 (3): 363-8 (Pubitemid 40165345)
4. Deanfield J, Donald A, Ferri C, et al. Endothelial function and dysfunction, part I: methodological issues for assessment in the different vascular beds - a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. J Hypertens 2005; 23 (1): 7-17 (Pubitemid 40128972)
5. Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation 2007; 115 (10): 1285-95 (Pubitemid 46594773)
6. Panza JA, Quyyumi AA, Brush JE, et al. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323 (1): 22-7 (Pubitemid 20209468)
7. Taddei S, Virdis A, Ghiadoni L, et al. Vitamin C improves endotheliumdependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation 1998; 97 (22): 2222-9 (Pubitemid 28265383)
8. Virdis A, Ghiadoni L, Cardinal H, et al. Mechanisms responsible for endothelial dysfunction induced by fasting hyperhomocystinemia in normotensive subjects and patients with essential hypertension. J Am Coll Cardiol 2001; 38 (4): 1106-15 (Pubitemid 32912719)
9. Taddei S, Versari D, Cipriano A, et al. Identification of a cytochrome P450 2C9-derived endothelium-derived hyperpolarizing factor in essential hypertensive patients. J Am Coll Cardiol 2006; 48 (3): 508-15 (Pubitemid 44093964)
10. Virdis A, Santini F, Colucci R, et al. Vascular generation of tumor necrosis factor-alpha reduces nitric oxide availability in small arteries from visceral fat of obese patients. J Am Coll Cardiol 2011; 58 (3): 238-47
11. Schiffrin EL. Vascular structure in NG-nitro-L-arginine methyl ester-induced hypertension: methodological considerations for studies of small arteries in hypertension. J Hypertens 1995; 13 (8): 817-21
12. Rizzoni D, Porteri E, Castellano M, et al. Endothelial dysfunction in hypertension is independent from the etiology and from vascular structure. Hypertension 1998; 31 (1 Pt 2): 335-41
13. Endemann DH, Pu Q, De Ciuceis C, et al. Persistent remodeling of resistance arteries in type 2 diabetic patients on antihypertensive treatment. Hypertension 2004; 43 (2): 399-404 (Pubitemid 38174146)
14. Rizzoni D, Porteri E, De Ciuceis C, et al. Lack of prognostic role of endothelial dysfunction in subcutaneous small resistance arteries of hypertensive patients. J Hypertens 2006; 24 (5): 867-73 (Pubitemid 43670457)
15. Wilkinson IB, Hall IR, MacCallum H, et al. Pulse-wave analysis: clinical evaluation of a noninvasive, widely applicable method for assessing endothelial function. Arterioscler Thromb Vasc Biol 2002; 22 (1): 147-52 (Pubitemid 34076246)
16. Kuvin JT, Patel AR, Sliney KA, et al. Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude.AmHeart J 2003; 146 (1): 168-74 (Pubitemid 36851317)
17. Goodhart DM, Anderson TJ. Role of nitric oxide in coronary arterial vasomotion and the influence of coronary atherosclerosis and its risks. Am J Cardiol 1998; 82 (9): 1034-9 (Pubitemid 28507083)
18. Egashira K, Suzuki S, Hirooka Y, et al. Impaired endothelium-dependent vasodilation of large epicardial and resistance coronary arteries in patients with essential hypertension: different responses to acetylcholine and substance P. Hypertension 1995; 25 (2): 201-6
19. Marzilli M, Taddei S, Virdis A, et al. Endothelial function and coronary microcirculation in essential hypertension. J Hypertens 1998; 16 Suppl. 8: S59-63 (Pubitemid 29118818)
20. Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000; 101 (16): 1899-906 (Pubitemid 30225269)
21. Solzbach U, Hornig B, Jeserich M, et al. Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients. Circulation 1997; 96 (5): 1513-9 (Pubitemid 27375345)